What Is GRGDSP TFA and Where Does It Come From?

GRGDSP TFA is the trifluoroacetate salt of the synthetic hexapeptide GRGDSP (Gly-Arg-Gly-Asp-Ser-Pro). The core RGD (Arg-Gly-Asp) tripeptide motif was first identified in fibronectin as the minimal sequence required for cell attachment mediated through integrin receptors, particularly α5β1 and αvβ3 integrins. The flanking residues Gly, Ser, and Pro in the GRGDSP sequence are derived from the native fibronectin context and influence the conformational presentation of the RGD motif.

The TFA designation indicates that the peptide is supplied as a trifluoroacetate salt, a common counter-ion introduced during reversed-phase HPLC purification of synthetic peptides. Researchers should be aware that residual TFA can affect certain cell-based assays; if required, the TFA counter-ion can be exchanged to a more biocompatible anion such as acetate or hydrochloride using ion-exchange or lyophilization procedures.

Key Research Applications of GRGDSP TFA

GRGDSP TFA is primarily used in studies of integrin-mediated cell adhesion, migration, and signaling. Common research applications include:

• Cell adhesion and spreading assays: GRGDSP peptides are coated onto surfaces or incorporated into hydrogels to promote integrin-dependent cell attachment in a controlled, defined manner.
• Biomaterial surface functionalization: The peptide is conjugated to synthetic scaffolds (e.g., PEG hydrogels, PLGA, silicone) to render them cell-adhesive, supporting tissue engineering and regenerative medicine research.
• Competitive inhibition assays: Soluble GRGDSP is used to competitively block integrin binding to extracellular matrix proteins, enabling researchers to dissect integrin-specific adhesion pathways.
• Drug delivery systems: RGD-bearing peptides are incorporated into nanoparticle or liposome formulations to target integrin-expressing cells.

The scrambled or inactive control peptide GRGESP or GRADSP is typically used alongside GRGDSP to confirm RGD-specific effects in experimental designs.

Storage, Reconstitution, and Handling Guidelines

Storage: GRGDSP TFA should be stored as a lyophilized powder at –20 °C, protected from moisture and light. Under these conditions, the peptide is expected to be stable for an extended period; consult the certificate of analysis (CoA) supplied with each lot for the specific retest date.

Reconstitution: The peptide is generally soluble in water and aqueous buffers (e.g., PBS, pH 7.4) at typical working concentrations. Prepare a stock solution by dissolving the lyophilized powder in sterile water or buffer, then filter-sterilize through a 0.22 µm membrane before use in cell-based assays. Avoid repeated freeze-thaw cycles; aliquot stock solutions prior to storage at –20 °C or –80 °C.

TFA considerations: For sensitive cell culture applications, if TFA content is a concern, the counter-ion can be exchanged prior to use. Contact Aladdin Scientific technical support for guidance on alternative salt forms if required.

Safety: Handle as a research chemical following standard laboratory safety practices. Refer to the Safety Data Sheet (SDS) for full hazard information.

Quality, Purity, and Regulatory Considerations

GRGDSP TFA (G650638) is supplied as a research-grade synthetic peptide. Purity is typically confirmed by reversed-phase HPLC, and molecular identity is verified by mass spectrometry (MS). Researchers should request the certificate of analysis (CoA) for the specific lot received to confirm purity grade, net peptide content, and water/TFA content, as these factors affect accurate preparation of molar concentrations.

Net peptide content: The stated mass of a peptide lot includes counter-ion (TFA), residual water, and any other excipients. Net peptide content (expressed as a percentage) should be used when calculating molar concentrations for experimental use. This information is available on the CoA.

Regulatory status: GRGDSP TFA is supplied for research use only (RUO) and is not intended for diagnostic, therapeutic, or clinical use.